<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28291842</article-id><article-id pub-id-type="pmc">5349672</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0173925</article-id><article-id pub-id-type="publisher-id">PONE-D-16-34586</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Nausea</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Nausea</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Drugs</subject><subj-group><subject>Analgesics</subject><subj-group><subject>Opioids</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pain Management</subject><subj-group><subject>Analgesics</subject><subj-group><subject>Opioids</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Drugs</subject><subj-group><subject>Opioids</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Processes</subject><subj-group><subject>Vomiting</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Processes</subject><subj-group><subject>Vomiting</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Vomiting</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Vomiting</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Head</subject><subj-group><subject>Eyes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Head</subject><subj-group><subject>Eyes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Ocular System</subject><subj-group><subject>Eyes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Ocular System</subject><subj-group><subject>Eyes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Head</subject><subj-group><subject>Ears</subject><subj-group><subject>Semicircular Canals</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Head</subject><subj-group><subject>Ears</subject><subj-group><subject>Semicircular Canals</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Sensory Perception</subject><subj-group><subject>Vision</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Psychology</subject><subj-group><subject>Sensory Perception</subject><subj-group><subject>Vision</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Social Sciences</subject><subj-group><subject>Psychology</subject><subj-group><subject>Sensory Perception</subject><subj-group><subject>Vision</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Reflexes</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Head</subject><subj-group><subject>Ears</subject><subj-group><subject>Inner Ear</subject><subj-group><subject>Otolith</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Head</subject><subj-group><subject>Ears</subject><subj-group><subject>Inner Ear</subject><subj-group><subject>Otolith</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Preventing opioid-induced nausea and vomiting: Rest your head and close your eyes?</article-title><alt-title alt-title-type="running-head">Does closing your eyes prevent OINV?</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Heuser</surname><given-names>Fabian</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schulz</surname><given-names>Christian</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sa&#x0011f;lam</surname><given-names>Murat</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ramaioli</surname><given-names>Cecilia</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Heuberger</surname><given-names>Maria</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wagner</surname><given-names>Klaus J.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Jahn</surname><given-names>Klaus</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schneider</surname><given-names>Erich</given-names></name><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Brandt</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Glasauer</surname><given-names>Stefan</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lehnen</surname><given-names>Nadine</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="aff" rid="aff007"><sup>7</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label><addr-line>Department of Anaesthesiology, Klinikum rechts der Isar, Technische Universit&#x000e4;t M&#x000fc;nchen, Munich, Germany</addr-line></aff><aff id="aff002"><label>2</label><addr-line>German Centre for Vertigo and Balance Disorders, Klinikum der Universit&#x000e4;t M&#x000fc;nchen, Munich, Germany</addr-line></aff><aff id="aff003"><label>3</label><addr-line>Department of Neurology, Klinikum der Universit&#x000e4;t M&#x000fc;nchen, Munich, Germany</addr-line></aff><aff id="aff004"><label>4</label><addr-line>Sch&#x000f6;n Klinik, Bad Aibling, Germany</addr-line></aff><aff id="aff005"><label>5</label><addr-line>Brandenburg University of Technology, Cottbus-Senftenberg, Germany</addr-line></aff><aff id="aff006"><label>6</label><addr-line>Institute for Clinical Neurosciences, Klinikum der Universit&#x000e4;t M&#x000fc;nchen, Munich, Germany</addr-line></aff><aff id="aff007"><label>7</label><addr-line>Department of Psychosomatic Medicine and Psychotherapy, Klinikum rechts der Isar, Technische Universit&#x000e4;t M&#x000fc;nchen, Munich, Germany</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Sakakibara</surname><given-names>Manabu</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Tokai University, JAPAN</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>FH, CS, MS, CR, MH, KJW, and KJ report no disclosures. ES is general manager and a shareholder of EyeSeeTec GmbH. TB and SG are shareholders of EyeSeeTec GmbH. NL is a shareholder and consultant to EyeSeeTec GmbH. This does not alter our adherence to PLOS ONE policies on sharing data and materials.</p></fn><fn fn-type="con"><p><list list-type="simple"><list-item><p><bold>Conceptualization:</bold> FH SG TB NL.</p></list-item><list-item><p><bold>Formal analysis:</bold> MS SG NL.</p></list-item><list-item><p><bold>Funding acquisition:</bold> NL.</p></list-item><list-item><p><bold>Investigation:</bold> FH CS KJW.</p></list-item><list-item><p><bold>Methodology:</bold> FH KJ ES TB SG NL.</p></list-item><list-item><p><bold>Software:</bold> MS SG.</p></list-item><list-item><p><bold>Supervision:</bold> NL.</p></list-item><list-item><p><bold>Validation:</bold> FH MS KJW ES TB SG NL.</p></list-item><list-item><p><bold>Visualization:</bold> MS CR.</p></list-item><list-item><p><bold>Writing &#x02013; original draft:</bold> CR MH ES SG NL.</p></list-item><list-item><p><bold>Writing &#x02013; review &#x00026; editing:</bold> CR MH NL.</p></list-item></list>
</p></fn><corresp id="cor001">* E-mail: <email>cecilia.ramaioli@lrz.uni-muenchen.de</email></corresp></author-notes><pub-date pub-type="epub"><day>14</day><month>3</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>12</volume><issue>3</issue><elocation-id>e0173925</elocation-id><history><date date-type="received"><day>29</day><month>8</month><year>2016</year></date><date date-type="accepted"><day>28</day><month>2</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; 2017 Heuser et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Heuser et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0173925.pdf"/><abstract><p>Although opioid-induced nausea and vomiting (OINV) is common and debilitating, its mechanism is still unclear. Recently, we suggested that opioids affect semicircular canal function and that this leads to a mismatch between canal input and other sensory information during head motion, which triggers OINV. Here, we assess if visual input is relevant for this mismatch. In a randomized-controlled crossover study 14 healthy men (26.9&#x000b1;3.4 years, mean&#x000b1;SD) were tested twice, once blindfolded and once with eyes open, with at least one-day washout. The opioid remifentanil was administered intravenously (0.15 &#x003bc;g/kg/min) for 60 minutes. After a thirty-minutes resting period, subjects&#x02019; head and trunk were passively moved. Nausea was rated before remifentanil start (T<sub>0</sub>), before the movement intervention (T<sub>30</sub>) and after 60 minutes (T<sub>60</sub>) of administration. At rest (T<sub>0</sub>, T<sub>30</sub>), median nausea ratings were zero whether subjects were blindfolded or not. Movement triggered nausea independently of visual input (nausea rating 1.5/3.0 (median/interquartile range) in the blindfolded, 2.5/6 in the eyes-open condition, &#x003c7;<sup>2</sup>(1) = 1.3, p = 0.25). As movement exacerbates OINV independently of visual input, a clash between visual and semicircular canal information is not the relevant trigger for OINV. To prevent OINV, emphasis should be put on head-rest, eye-closure is less important.</p></abstract><funding-group><funding-statement>This work was supported by the German Federal Ministry of Education and Research (Grants 01 EO 0901 and 01 EO 0914). The funder "Sch&#x000f6;n Klinik Bad Aibling" provided support in the form of salaries for author KJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the &#x02018;author contributions&#x02019; section.</funding-statement></funding-group><counts><fig-count count="1"/><table-count count="0"/><page-count count="6"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Opioids are essential in the treatment of moderate to severe pain [<xref rid="pone.0173925.ref001" ref-type="bibr">1</xref>], but also induce debilitating nausea and vomiting. Opioid-induced nausea and vomiting (OINV) occurs in a third of all patients treated with morphine-equivalents [<xref rid="pone.0173925.ref002" ref-type="bibr">2</xref>] and is one of the main reasons for post-operative nausea and vomiting (PONV) [<xref rid="pone.0173925.ref003" ref-type="bibr">3</xref>]. PONV is a significant factor in complications such as pulmonary aspiration, dehydration, and electrolyte imbalance, delaying discharge and leading to hospital admission after ambulatory surgery, which greatly increases health care cost [<xref rid="pone.0173925.ref004" ref-type="bibr">4</xref>]. PONV negatively impacts patient satisfaction [<xref rid="pone.0173925.ref005" ref-type="bibr">5</xref>] and patients even rank it amongst the most distressing non-life-threatening side effects [<xref rid="pone.0173925.ref001" ref-type="bibr">1</xref>].</p><p>The exact mechanism of OINV is still not clear. Opioids affect vestibular function, as demonstrated by a decrease in caloric response with morphine [<xref rid="pone.0173925.ref006" ref-type="bibr">6</xref>], a diminished active vestibulo-ocular reflex (VOR) with pethidine and fentanyl administration [<xref rid="pone.0173925.ref007" ref-type="bibr">7</xref>], vestibular dysfunction with heroin abuse [<xref rid="pone.0173925.ref008" ref-type="bibr">8</xref>], and decreased semicircular canal function, measured by the VOR gain, during administration of the short-acting &#x003bc;-agonist remifentanil [<xref rid="pone.0173925.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0173925.ref010" ref-type="bibr">10</xref>]. Opioid receptors are present within the VOR-three-neuron arc [<xref rid="pone.0173925.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0173925.ref012" ref-type="bibr">12</xref>] and in the cerebellum [<xref rid="pone.0173925.ref013" ref-type="bibr">13</xref>], and could mediate the changes in vestibular-ocular motor function (VOR gain). Additional oculomotor findings during opioid administration, such as gaze-evoked nystagmus, saccadic smooth pursuit and, in particular, downbeat-nystagmus, point to cerebellar involvement [<xref rid="pone.0173925.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0173925.ref009" ref-type="bibr">9</xref>].</p><p>Importantly, we demonstrated that head movement greatly exacerbates nausea during administration of the opioid remifentanil, while resting protects from it [<xref rid="pone.0173925.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0173925.ref014" ref-type="bibr">14</xref>]. We suggested that the change in semicircular canal input during remifentanil administration leads to a mismatch between this information and that of other sensors when the head is moved, triggering nausea and vomiting [<xref rid="pone.0173925.ref009" ref-type="bibr">9</xref>].</p><p>To understand the role of visual input for this mismatch and, practically, to assess whether, in addition to avoiding head movement, it makes sense to close the eyes to decrease OINV, we examined motion-dependent nausea during opioid administration with and without vision.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and methods</title><sec id="sec003"><title>Standard protocol approvals, registrations, and patient consent</title><p>Fourteen healthy men aged 26.9&#x000b1;3.4 years (mean&#x000b1;SD) gave their written consent to the study that was approved by the Ethics Committee of Technische Universit&#x000e4;t M&#x000fc;nchen&#x02019;s Medical Faculty and performed in accordance with the Declaration of Helsinki. Subjects were free to withdraw from the experiment at any time. They were financially remunerated for taking part in the study. Subjects did not suffer from any balance disorders and were not taking any medication, explicitly no opioids.</p></sec><sec id="sec004"><title>Opioid administration</title><p>Remifentanil, chosen because of its well-known and controllable characteristics, was administered intravenously (0.15 &#x003bc;g/kg/min, in analogy to Lehnen et al. [<xref rid="pone.0173925.ref009" ref-type="bibr">9</xref>]) during standard monitoring (ECG, non-invasive blood pressure, pulse, pulsoxymetry).</p></sec><sec id="sec005"><title>Experimental conditions</title><p>Subjects were divided into two subgroups of equal age (26.4&#x000b1;3.5 and 27.3&#x000b1;3.6 years, mean&#x000b1;SD), motion-sickness-susceptibility score (assessed by the Motion Sickness Susceptibility Questionnaire, MSSQ-Short [<xref rid="pone.0173925.ref015" ref-type="bibr">15</xref>], 5.9&#x000b1;9.2 and 5.9&#x000b1;5.8 points) and postoperative-nausea-and-vomiting risk [<xref rid="pone.0173925.ref003" ref-type="bibr">3</xref>] (20&#x000b1;9.7% and 22&#x000b1;8.5%). In a crossover design, each subject was tested twice with at least one-day washout. Seven subjects were first tested &#x0201c;blindfolded,&#x0201d; then &#x0201c;eyes-open&#x0201d;, and vice-versa. In the condition &#x0201c;blindfolded&#x0201d;, subjects wore eye patches for the entire duration of the experiment. They were resting in a semi-recumbent position during 60 minutes of remifentanil administration (<xref ref-type="fig" rid="pone.0173925.g001">Fig 1A</xref>). After remifentanil had been administered for 30 minutes, subjects were bent forward and backward ten times at a frequency of 1 Hz. The condition &#x0201c;eyes-open&#x0201d; was the same as the &#x0201c;blindfolded&#x0201d; condition, but the subjects were not blinded and were encouraged to keep their eyes open.</p><fig id="pone.0173925.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0173925.g001</object-id><label>Fig 1</label><caption><p>A. Experimental design (crossover study). Subjects rested in a semi-recumbent position while remifentanil was continuously administered intravenously. After 30 minutes, subjects were bent forward and backward ten times at a frequency of 1 Hz (&#x0201c;Move&#x0201d;) after which they rested again for 30 minutes. Nausea was assessed on a numerical scale from 0 (no nausea) to 10 (vomiting) before the remifentanil infusion (T<sub>0</sub>), during the 30 minutes of rest with remifentanil administration (T<sub>30</sub>), and during the 30 minutes (T<sub>60</sub>) after the movement intervention. The study contained two conditions: in the &#x0201c;blindfolded&#x0201d; condition subjects wore an eye patch during the entire duration of the experiment, while in the &#x0201c;eyes-open&#x0201d; condition subjects were encouraged to leave their eyes open. In a crossover design with at least one-day of washout, seven subjects were first tested with the condition &#x0201c;blindfolded&#x0201d; and then &#x0201c;eyes-open&#x0201d;, and vice versa. B. Effects of movement on nausea during remifentanil administration with and without visual input. Median (horizontal line), interquartile range (box) of nausea values quantified on a numerical scale from 0 (no nausea) to 10 (vomiting) in conditions &#x0201c;eyes-open&#x0201d; (white) and &#x0201c;blindfolded&#x0201d; (grey). Crosses designate outliers (outside 75-percentile + 1.5x interquartile range). Whiskers extend to the closest data value not considered an outlier. Data from the two subgroups of the crossover design was pooled, as there was no difference between the subgroups in all conditions (all p&#x0003e;0.20). During rest, nausea ratings did not differ at any time point (T<sub>0</sub>, T<sub>30</sub> of both conditions; all medians zero, p = 0.26). Movement led to a marked increase in nausea (difference between T<sub>0</sub>, T<sub>30</sub>, and T<sub>60</sub>, &#x0201c;blindfolded&#x0201d;: p = 0.012, &#x0201c;eyes-open&#x0201d;: p&#x0003c;0.001), independently of visual input (no difference between nausea ratings at T<sub>60</sub> in the "blindfolded" and "eyes-open" condition, p = 0.25)</p></caption><graphic xlink:href="pone.0173925.g001"/></fig><p>Subjects rated nausea on a scale from zero (no nausea) to ten (vomiting) before receiving remifentanil (T<sub>0</sub>), after the period of 30 minutes rest (before being moved, T<sub>30</sub>) and after the 30 minutes following the movement intervention (T<sub>60</sub>). Maximal ratings for each period were analysed.</p></sec><sec id="sec006"><title>Statistical analysis</title><p>Data were analysed offline in Matlab<sup>&#x000ae;</sup> (Mathworks<sup>&#x000ae;</sup>, Natick, MA). Differences in nausea ratings between subgroups were assessed with an independent samples Mann-Whitney-U test (factor <italic>order</italic>), differences within <italic>time</italic> points T<sub>0</sub>, T<sub>30</sub> and T<sub>60</sub> of both <italic>conditions</italic> (&#x0201c;blindfolded&#x0201d;, &#x0201c;eyes-open&#x0201d;) with a related samples Friedman&#x02019;s ANOVA-by-ranks (significance level p&#x0003c;0.05).</p></sec></sec><sec sec-type="results" id="sec007"><title>Results</title><p>Nausea ratings did not differ between the subgroups for each <italic>time</italic> point (T<sub>0</sub>, T<sub>30</sub>, T<sub>60</sub>). Therefore they were independent of the <italic>order</italic> of the conditions (all p&#x0003e;0.20), and consequently, data for both subgroups of the crossover design were pooled. <xref ref-type="fig" rid="pone.0173925.g001">Fig 1B</xref> shows nausea ratings for the &#x0201c;eyes-open&#x0201d; and the &#x0201c;blindfolded&#x0201d; <italic>conditions</italic> at rest (T<sub>0</sub>, T<sub>30</sub>) and during the 30 minutes after the movement intervention (T<sub>60</sub>). At rest, nausea ratings did not differ for all <italic>times</italic> T<sub>0</sub> and T<sub>30</sub> of both <italic>conditions</italic> (all medians zero; &#x003c7;<sup>2</sup>(3) = 4.0, p = 0.26). Comparison of T<sub>0</sub>, T<sub>30</sub>, and T<sub>60</sub> within the conditions revealed that movement triggered nausea in both <italic>conditions</italic> (&#x0201c;blindfolded&#x0201d;: &#x003c7;<sup>2</sup>(2) = 8.9, p = 0.012, &#x0201c;eyes-open&#x0201d;: &#x003c7;<sup>2</sup>(2) = 16.7,p&#x0003c;0.001). Nausea ratings during T<sub>60</sub> did not differ between the <italic>conditions</italic> (&#x003c7;<sup>2</sup>(1) = 1.3, p = 0.25, &#x0201c;eyes-open&#x0201d; 2.5/6.0 (median/interquartile range), &#x0201c;blindfolded&#x0201d; 1.5/3.0).</p></sec><sec sec-type="conclusions" id="sec008"><title>Discussion</title><p>Nausea during remifentanil administration was triggered by movement and avoided by rest in all subjects independently of visual input. This suggests that vision is not the major cause for an inter-sensory mismatch with semicircular canal input during head motion.</p><p>Remifentanil reversibly affects vestibulo-ocular reflex function, as measured by the VOR gain of the horizontal semicircular canals [<xref rid="pone.0173925.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0173925.ref010" ref-type="bibr">10</xref>]. This altered information could clash with neck proprioception or other vestibular sensory information. An intra-vestibular mismatch between reduced horizontal semicircular canals [<xref rid="pone.0173925.ref009" ref-type="bibr">9</xref>] and not accordingly altered otolith signals seems likely. Such an intra-vestibular mismatch is acknowledged as a causative factor for seasickness (for review, see Bertolini&#x00026;Straumann, 2016 [<xref rid="pone.0173925.ref016" ref-type="bibr">16</xref>]) and also seems to provoke space sickness where altered otolith signals in weightlessness clash with regular semicircular canal input [<xref rid="pone.0173925.ref017" ref-type="bibr">17</xref>].</p><p>Our study confirms the head-motion dependence of OINV with a striking median of zero on the nausea scale during rest in all conditions. As in our prior work, the incidence of OINV in our study (57/64% or 8/9 out of the 14 subjects in the &#x0201c;blindfolded&#x0201d;/&#x0201c;eyes-open&#x0201d; conditions) is higher than that predicted by the standard risk score[<xref rid="pone.0173925.ref003" ref-type="bibr">3</xref>] for post-operative nausea and vomiting (21&#x000b1;9%, mean&#x000b1;SD or 3/14). This is possibly because the risk score does not control for head movement, i.e., not all patients included in the calculation of the score might have experienced perioperative movement interventions similar to the ones in our study. It should be noted that there is a limitation to the interpretation of this exploratory approach due to the relatively small sample size and the fact that only men were tested.</p><p>In conclusion, our study suggests that an intra-vestibular, and not a visual-vestibular, mismatch that becomes apparent during movement exacerbates OINV. Resting thus protects from OINV, while closing the eyes appears less important. Understanding this mechanism will improve pain management with opioids. In clinical practice, especially during transient opioid application, OINV could be reduced by avoiding head movement, e.g. with a head immobilizer peri-operatively.</p></sec></body><back><ack><p>We thank Judy Benson for copy-editing the manuscript.</p></ack><ref-list><title>References</title><ref id="pone.0173925.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Porreca</surname><given-names>F</given-names></name>, <name><surname>Ossipov</surname><given-names>MH</given-names></name> (<year>2009</year>) <article-title>Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanisms, implications, and management options</article-title>. <source>Pain medicine</source>
<volume>10</volume>: <fpage>654</fpage>&#x02013;<lpage>662</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1526-4637.2009.00583.x">10.1111/j.1526-4637.2009.00583.x</ext-link></comment>
<pub-id pub-id-type="pmid">19302436</pub-id></mixed-citation></ref><ref id="pone.0173925.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Gan</surname><given-names>TJ</given-names></name> (<year>2002</year>) <article-title>Postoperative nausea and vomiting&#x02014;can it be eliminated?</article-title>
<source>JAMA</source>
<volume>287</volume>: <fpage>1233</fpage>&#x02013;<lpage>1236</lpage>. <pub-id pub-id-type="pmid">11886298</pub-id></mixed-citation></ref><ref id="pone.0173925.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Apfel</surname><given-names>CC</given-names></name>, <name><surname>Laara</surname><given-names>E</given-names></name>, <name><surname>Koivuranta</surname><given-names>M</given-names></name>, <name><surname>Greim</surname><given-names>CA</given-names></name>, <name><surname>Roewer</surname><given-names>N</given-names></name> (<year>1999</year>) <article-title>A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers</article-title>. <source>Anesthesiology</source>
<volume>91</volume>: <fpage>693</fpage>&#x02013;<lpage>700</lpage>. <pub-id pub-id-type="pmid">10485781</pub-id></mixed-citation></ref><ref id="pone.0173925.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Habib</surname><given-names>AS</given-names></name>, <name><surname>Chen</surname><given-names>YT</given-names></name>, <name><surname>Taguchi</surname><given-names>A</given-names></name>, <name><surname>Hu</surname><given-names>XH</given-names></name>, <name><surname>Gan</surname><given-names>TJ</given-names></name> (<year>2006</year>) <article-title>Postoperative nausea and vomiting following inpatient surgeries in a teaching hospital: a retrospective database analysis</article-title>. <source>Curr Med Res Opin</source>
<volume>22</volume>: <fpage>1093</fpage>&#x02013;<lpage>1099</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1185/030079906X104830">10.1185/030079906X104830</ext-link></comment>
<pub-id pub-id-type="pmid">16846542</pub-id></mixed-citation></ref><ref id="pone.0173925.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Myles</surname><given-names>PS</given-names></name>, <name><surname>Williams</surname><given-names>DL</given-names></name>, <name><surname>Hendrata</surname><given-names>M</given-names></name>, <name><surname>Anderson</surname><given-names>H</given-names></name>, <name><surname>Weeks</surname><given-names>AM</given-names></name> (<year>2000</year>) <article-title>Patient satisfaction after anaesthesia and surgery: results of a prospective survey of 10,811 patients</article-title>. <source>Br J Anaesth</source>
<volume>84</volume>: <fpage>6</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="pmid">10740539</pub-id></mixed-citation></ref><ref id="pone.0173925.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Rubin</surname><given-names>A</given-names></name>, <name><surname>Winston</surname><given-names>J</given-names></name> (<year>1950</year>) <article-title>The role of the vestibular apparatus in the production of nausea and vomiting following the administration of morphine to man; clinical and experimental data including the effects of dramamine and benzedrine</article-title>. <source>J Clin Invest</source>
<volume>29</volume>: <fpage>1261</fpage>&#x02013;<lpage>1266</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1172/JCI102363">10.1172/JCI102363</ext-link></comment>
<pub-id pub-id-type="pmid">14778889</pub-id></mixed-citation></ref><ref id="pone.0173925.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Rottach</surname><given-names>KG</given-names></name>, <name><surname>Wohlgemuth</surname><given-names>WA</given-names></name>, <name><surname>Dzaja</surname><given-names>AE</given-names></name>, <name><surname>Eggert</surname><given-names>T</given-names></name>, <name><surname>Straube</surname><given-names>A</given-names></name> (<year>2002</year>) <article-title>Effects of intravenous opioids on eye movements in humans: possible mechanisms</article-title>. <source>J Neurol</source>
<volume>249</volume>: <fpage>1200</fpage>&#x02013;<lpage>1205</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00415-002-0806-1">10.1007/s00415-002-0806-1</ext-link></comment>
<pub-id pub-id-type="pmid">12242539</pub-id></mixed-citation></ref><ref id="pone.0173925.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Ishiyama</surname><given-names>A</given-names></name>, <name><surname>Ishiyama</surname><given-names>G</given-names></name>, <name><surname>Baloh</surname><given-names>RW</given-names></name>, <name><surname>Evans</surname><given-names>CJ</given-names></name> (<year>2001</year>) <article-title>Heroin-induced reversible profound deafness and vestibular dysfunction</article-title>. <source>Addiction</source>
<volume>96</volume>: <fpage>1363</fpage>&#x02013;<lpage>1364</lpage>. <pub-id pub-id-type="pmid">11683145</pub-id></mixed-citation></ref><ref id="pone.0173925.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Lehnen</surname><given-names>N</given-names></name>, <name><surname>Heuser</surname><given-names>F</given-names></name>, <name><surname>Saglam</surname><given-names>M</given-names></name>, <name><surname>Schulz</surname><given-names>CM</given-names></name>, <name><surname>Wagner</surname><given-names>KJ</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Opioid-Induced Nausea Involves a Vestibular Problem Preventable by Head-Rest</article-title>. <source>PLoS One</source>
<volume>10</volume>: <fpage>e0135263</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0135263">10.1371/journal.pone.0135263</ext-link></comment>
<pub-id pub-id-type="pmid">26313751</pub-id></mixed-citation></ref><ref id="pone.0173925.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Ramaioli</surname><given-names>C</given-names></name>, <name><surname>Colagiorgio</surname><given-names>P</given-names></name>, <name><surname>Saglam</surname><given-names>M</given-names></name>, <name><surname>Heuser</surname><given-names>F</given-names></name>, <name><surname>Schneider</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>The effect of vestibulo-ocular reflex deficits and covert saccades on dynamic vision in opioid-induced vestibular dysfunction</article-title>. <source>PLoS One</source>
<volume>9</volume>: <fpage>e110322</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0110322">10.1371/journal.pone.0110322</ext-link></comment>
<pub-id pub-id-type="pmid">25329150</pub-id></mixed-citation></ref><ref id="pone.0173925.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Carpenter</surname><given-names>DO</given-names></name>, <name><surname>Hori</surname><given-names>N</given-names></name> (<year>1992</year>) <article-title>Neurotransmitter and peptide receptors on medial vestibular nucleus neurons</article-title>. <source>Ann N Y Acad Sci</source>
<volume>656</volume>: <fpage>668</fpage>&#x02013;<lpage>686</lpage>. <pub-id pub-id-type="pmid">1350895</pub-id></mixed-citation></ref><ref id="pone.0173925.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Popper</surname><given-names>P</given-names></name>, <name><surname>Cristobal</surname><given-names>R</given-names></name>, <name><surname>Wackym</surname><given-names>PA</given-names></name> (<year>2004</year>) <article-title>Expression and distribution of mu opioid receptors in the inner ear of the rat</article-title>. <source>Neuroscience</source>
<volume>129</volume>: <fpage>225</fpage>&#x02013;<lpage>233</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.neuroscience.2004.08.008">10.1016/j.neuroscience.2004.08.008</ext-link></comment>
<pub-id pub-id-type="pmid">15489044</pub-id></mixed-citation></ref><ref id="pone.0173925.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Platzer</surname><given-names>S</given-names></name>, <name><surname>Winkler</surname><given-names>A</given-names></name>, <name><surname>Schadrack</surname><given-names>J</given-names></name>, <name><surname>Dworzak</surname><given-names>D</given-names></name>, <name><surname>Tolle</surname><given-names>TR</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>Autoradiographic distribution of mu-, delta- and kappa 1-opioid stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in human frontal cortex and cerebellum</article-title>. <source>Neurosci Lett</source>
<volume>283</volume>: <fpage>213</fpage>&#x02013;<lpage>216</lpage>. <pub-id pub-id-type="pmid">10754225</pub-id></mixed-citation></ref><ref id="pone.0173925.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Heuser</surname><given-names>F</given-names></name>, <name><surname>Schulz</surname><given-names>CM</given-names></name>, <name><surname>Hapfelmeier</surname><given-names>A</given-names></name>, <name><surname>Lehnen</surname><given-names>N</given-names></name>, <name><surname>Kochs</surname><given-names>EF</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>A period of immobility after remifentanil administration protects from nausea: an experimental randomized cross-over study</article-title>. <source>BMC Anesthesiol</source>
<volume>16</volume>: <fpage>90</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/s12871-016-0263-5">10.1186/s12871-016-0263-5</ext-link></comment>
<pub-id pub-id-type="pmid">27724859</pub-id></mixed-citation></ref><ref id="pone.0173925.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Golding</surname><given-names>JF</given-names></name> (<year>1998</year>) <article-title>Motion sickness susceptibility questionnaire revised and its relationship to other forms of sickness</article-title>. <source>Brain Res Bull</source>
<volume>47</volume>: <fpage>507</fpage>&#x02013;<lpage>516</lpage>. <pub-id pub-id-type="pmid">10052582</pub-id></mixed-citation></ref><ref id="pone.0173925.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Bertolini</surname><given-names>G</given-names></name>, <name><surname>Straumann</surname><given-names>D</given-names></name> (<year>2016</year>) <article-title>Moving in a Moving World: A Review on Vestibular Motion Sickness</article-title>. <source>Front Neurol</source>
<volume>7</volume>: <fpage>14</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3389/fneur.2016.00014">10.3389/fneur.2016.00014</ext-link></comment>
<pub-id pub-id-type="pmid">26913019</pub-id></mixed-citation></ref><ref id="pone.0173925.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Thornton</surname><given-names>WE</given-names></name>, <name><surname>Bonato</surname><given-names>F</given-names></name> (<year>2013</year>) <article-title>Space motion sickness and motion sickness: symptoms and etiology</article-title>. <source>Aviat Space Environ Med</source>
<volume>84</volume>: <fpage>716</fpage>&#x02013;<lpage>721</lpage>. <pub-id pub-id-type="pmid">23855067</pub-id></mixed-citation></ref></ref-list></back></article>